Initial Clinical Response Predicts Outcome and Is Associated With Dose Schedule in Metastatic Melanoma and Renal Cell Carcinoma Patients Treated With High-Dose Interleukin 2
2005; Springer Science+Business Media; Volume: 12; Issue: 5 Linguagem: Inglês
10.1245/aso.2005.03.063
ISSN1534-4681
AutoresKathryn Spanknebel, Kenneth Cheung, John Stoutenburg, Karl S Hurst-Wicker, Charles Hesdorffer, Gail DeRaffele, and Howard L. Kaufman,
Tópico(s)Cutaneous Melanoma Detection and Management
Referência(s)